Evidence map›Paper›PMID 30080900›Full record

ArticlePLoS pathogens2018

Reconstruction of the cell entry pathway of an extinct virus.

Lindsey R Robinson-McCarthy, Kevin R McCarthy, Matthijs Raaben, Silvia Piccinotti, Joppe Nieuwenhuis, Sarah H Stubbs, Mark J G Bakkers, Sean P J Whelan

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The prefusion structure of the HERV-K (HML-2) Env spike complex.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Lindsey R Robinson-McCarthyProgram in Virology, Harvard Medical School, Boston, Massachusetts, United States of America.
Kevin R McCarthyLaboratory of Molecular Medicine, Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0003-1016-6015
Matthijs RaabenDivision of Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Silvia PiccinottiDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0001-8702-7510
Joppe NieuwenhuisDivision of Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID 0000-0003-4738-5895
Sarah H StubbsDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America.
Mark J G BakkersDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0001-8957-1392
Sean P J WhelanProgram in Virology, Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0003-1564-8590
Harvard University · USThe Netherlands Cancer Institute · NLBoston Children's Hospital · US

Funding

Small-molecule inhibitors of flavivirus entryU19AI109740 · NIAID · HARVARD MEDICAL SCHOOL · PI WHELAN, SEAN PJ · 2014 to 2018
$23.0M
Molecular Mechanisms of Rhabdovirus EntryR01AI081842 · NIAID · HARVARD MEDICAL SCHOOL · PI WHELAN, SEAN PJ · 2010 to 2014
$2.0M
Molecular Mechanisms of Rhabdovirus EntryR56AI081842 · NIAID · HARVARD MEDICAL SCHOOL · PI WHELAN, SEAN PJ · 2009 to 2009
$167k
NIAID NIH HHS R01 AI081842NIAID NIH HHS R56 AI081842NIAID NIH HHS U19 AI109740
6 · The paper itself

Abstract

Endogenous retroviruses (ERVs), remnants of ancient germline infections, comprise 8% of the human genome. The most recently integrated includes human ERV-K (HERV-K) where several envelope (env) sequences remain intact. Viral pseudotypes decorated with one of those Envs are infectious. Using a recombinant vesicular stomatitis virus encoding HERV-K Env as its sole attachment and fusion protein (VSV-HERVK) we conducted a genome-wide haploid genetic screen to interrogate the host requirements for infection. This screen identified 11 genes involved in heparan sulfate biosynthesis. Genetic inhibition or chemical removal of heparan sulfate and addition of excess soluble heparan sulfate inhibit infection. Direct binding of heparin to soluble HERV-K Env and purified VSV-HERVK defines it as critical for viral attachment. Cell surface bound VSV-HERVK particles are triggered to infect on exposure to acidic pH, whereas acid pH pretreatment of virions blocks infection. Testing of additional endogenous HERV-K env sequences reveals they bind heparin and mediate acid pH triggered fusion. This work reconstructs and defines key steps in the infectious entry pathway of an extinct virus.

Indexed as

Virus InternalizationEndogenous RetrovirusesHeparan SulfateHumansViral Envelope ProteinsViral TropismHeparan SulfateViral Envelope Proteins

Identifiers

PMID30080900
PMCPMC6095630
OpenAlexW2950973961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.